Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection

Virology

Volumn 261, Issue 2, 1999, Pages 173-179

  Dutia, B M ^a   Allen, D J ^a   Dyson, H ^a   Nash, A A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 1; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME INDUCTION; HERPES VIRUS INFECTION; HOST RESISTANCE; INFECTION CONTROL; INFECTION SENSITIVITY; LATENT VIRUS INFECTION; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALIA; DNA VIRUSES; HERPES; HERPESVIRIDAE; MURINAE; MURINE HEPATITIS VIRUS;

EID: 0033199331     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9834     Document Type: Article

References (34)

1. Aguet M., Mogensen K. E. Gresser I. Interferon 5. 1983;1-22 Academic Press, New York.
2. Aman P., von Gabain A. An Epstein-Barr virus immortalization associated gene segment interferes specifically with the IFN-induced anti-proliferative response in human B-lymphoid cell lines. EMBO J. 9:1990;147-152.
3. Bach E. A., Aguet M., Schreiber R. D. The IFN-γ Receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:1997;563-591.
4. Biron C. A. Natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:1997;24-34.
5. Biron C. A. Role of early cytokines, including alpha and beta interferons (IFN-α/β) in innate and adaptive immune responses to viral infections. Semin. Immunol. 10:1998;383-390.
6. Blaskovic D., Stancekova J., Svobodova J., Mistrikova J. Isolation of five strains of herpesviruses from two species of freeliving small rodents. Acta Virol. 24:1980;468.
7. + T cells. J. Exp. Med. 184:1996;863-871.
8. Clarke P. A., Schwemmle M., Schickinger J., Hilse K., Clemens M. J. Binding of Epstein-Barr virus small RNA EBER-1 to the double stranded RNA-activated protein kinase DAI. Nucleic Acids Res. 19:1991;243-248.
9. Diefenbach A., Schindler H., Donhauser N., Lorenz E., Laskay T., MacMicking J., Rollinghoff M., Gresser I., Bogdan C. Type I interferon (IFNα/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 8:1998;77-87.
10. Duncan G. S., Mittrucker H., Kagi D., Matsuyama T., Mak T. W. The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J. Exp. Med. 184:1996;2043-2048.
11. Dutia B. M., Clarke C. J., Allen D. A., Nash A. A. Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: A role for CD8 T cells. J. Virol. 71:1997;4278-4283.
12. Efstathiou S., Ho Y. M., Hall S., Styles C. J., Scott S. D., Gompels U. A. Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr and herpesvirus Saimiri. J. Gen. Virol. 71:1990;1365-1372.
13. Ethisham S., Sunil-Chandra N. P., Nash A. A. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J. Virol. 67:1993;5247-5252.
14. Fish E. N., Banerjee K., Stebbing N. Antiviral activities of cloned human leukocyte interferons against herpes simplex type 2 infections of mice. J. Gen. Virol. 64:1983;2317-2321.
15. Kimura T., Nakayama K., Penninger J., Kitagawa M., Harada H., Matsuyama T., Tanaka N., Kamijo R., Vilcek J., Mak T. W., Taniguchi T. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science. 264:1994;1921-1924.
16. Kulkarni A. B., Holmes K. L., Fredrickson T. N., Hartley J. W., Morse H. C. I. Characteristics of a murine gammaherpesvirus infection immunocompromised mice. In Vivo. 11:1997;281-292.
17. Lohoff M., Ferrick D., Mittrucker H., Duncan G. S., Bischoff S., Rollinghoff M., Mak T. W. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity. 6:1997;681-689.
18. Matsuyama T., Kimura T., Kitagawa M., Pfeffer K., Kawakami T., Watanabe N., Kundig T. M., Amakawa R., Kishihara K., Wakeham A., Potter J., Furlonger C. L., Nerendran A., Suzuki H., Ohashi P. S., Paige C. J., Taniguchi T., Mak T. W. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell. 75:1993;83-97.
19. Miyamoto M., Fujita T., Kimura Y., Maruyama m., Harada H., Sudo Y., Miyata T., Taniguchi T. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell. 75:1988;83-87.
20. Muller U., Steinhoff U., Reis L. F. L., Hemmi S., Pavlovic J., Zinkernagel R. M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 264:1994;1918-1921.
21. Nash A. A., Usherwood E. J., Stewart J. P. Immunological features of murine gammaherpesvirus infection. Semin. Virol. 7:1996;125-130.
22. Pine R., Levy D. E., Reich N., Darnell J. E. J. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol. 10:1990;2448-2457.
23. Rasmussen L., Farley L. B. Inhibition of herpesvirus hominis replication by human interferon. Infect. Immunol. 12:1975;104-108.
24. Reis L. F. L., Harada H., Wolchok J. D., Taniguchi T., Vilcek J. Critical role of a common transcription factor, IRF-1, in the regulation of IFN-β and IFN-inducible genes. EMBO J. 11:1992;185-193.
25. Sunil-Chandra N. P., Efstathiou S., Arno J., Nash A. A. Virological and pathological features of mice infected with murine gammaherpesvirus 68. J. Gen. Virol. 73:1992a;2347-2356.
26. Sunil-Chandra N. P., Efstathiou S., Nash A. A. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73:1992b;3275-3279.
27. Tough D. E., Borrow P., Sprent J. Induction of bystander T-cell proliferation by viruses and type I interferon in vivo. Science. 272:1996;1947-1950.
28. Tripp R. A., Hamilton-Easton A. M., Cardin R. D., Nguyen P., Bemn F. G., Woodlane D. L., Doherty P. C., Blackman M. A. Pathogenesis of an infectious mononucleosis-like disease induced by a murine γ-herpesvirus: Role for a viral superantigen. J. Exp. Med. 185:1997;1641-1650.
29. Usherwood E. J., Ross A. J., Allen D. J., Nash A. A. Murine gammaherpesvirus-induced splenomegaly: A critical role for CD4 T cells. J. Gen. Virol. 77:1996a;627-630.
30. Usherwood E. J., Stewart J. P., Robertson K., Allen D. J., Nash A. A. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J. Gen. Virol. 77:1996b;2819-2825.
31. Van den Broek M. F., Muller U., Huang S., Zinkernagel R. M., Aguet M. Immune defence in mice lacking type I and/or type II interferon receptor. Immunol. Rev. 148:1995;5-18.
32. Vilcek J., Sen G. C. Interferons and other cytokines. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;375-399 Lippincott-Raven, Philadelphia.
33. Weck K. E., Dal Canto A. J., Gould J. D., O'Guin A. K., Roth K. A., Saffitz J. E., Speck S. H., Virgin H. W. I. Murine γ-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-γ responsiveness: A new model for virus-induced vascular disease. Nat. Med. 3:1997;1346-1353.
34. Wei X., Charles I. G., Smith A., Ure J., Feng G., Huang F., Xu D., Muller W., Moncada S., Liew F. Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.